The cost of systemic therapy for metastatic colorectal carcinoma in Slovenia: discrepancy analysis between cost and reimbursement.

Mesti, Tanja; Boshkoska, Biljana Mileva; Kos, Mitja; Tekavcic, Metka; Ocvirk, Janja

Mesti, Tanja; Boshkoska, Biljana Mileva; Kos, Mitja; Tekavcic, Metka; Ocvirk, Janja.

Afiliação

Mesti T; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Boshkoska BM; Faculty of information studies, Novo mesto, Slovenia.
Kos M; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
Tekavcic M; Faculty of Economics, University of Ljubljana, Ljubljana, Slovenia.
Ocvirk J; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.

Radiol Oncol ; 49(2): 200-8, 2015 Jun.

Article em En | MEDLINE | ID: mdl-26029033

Palavras-chave

cost of targeted therapy; cost of treatment; metastatic colorectal cancer; monitoring costs

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Radiol Oncol Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google